Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, we wish to inform you that the Trading Window for dealing in securities of the Company shall remain closed with effect from April 01, 2026 and shall be opened 48 (Forty-Eight) hours after the conclusion of the Meeting of the Board of Directors to be held for the purpose of declaration of Audited Standalone Financial Results for the Quarter and year ended March 31, 2026.
Closure of Trading Window
View original source (BSE India)Trident Texofab Ltd. on 6ix
Earlier from Trident Texofab
- Trident Texofab Ltd. Press Release Mar 27 2026
- Outcome of the separate meeting of independent directors of the company held on 27.03.2026
- Trident Texofab Ltd. Press Release Feb 12 2026
- Statement Of Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter Ended 31.12.2025
- Result- Financial Result Of The Quarter And Nine Months Ended 31St December, 2025
Later from Trident Texofab
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Trident Texofab Ltd. Press Release Apr 08 2026
- Reply to the clarification sought on price movement
- Trident Texofab Ltd. Press Release Apr 16 2026
- Trident Texofab Ltd. Press Release Apr 30 2026
Follow Trident Texofab into a list and get an email when it puts out news.
Follow Trident Texofab